Pharmaceutically active morpholinol
US6855820B2 · kind B2 · utility
8Cited by
50References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 17, 2002 |
| Grant date | Feb 15, 2005 |
| Priority date | — |
| Expiry date | May 17, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/5375
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is the compound (+)-(2S,3S)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol and pharmaceutically acceptable salts and solvates thereof, methods for preparing them, pharmaceutical compositions comprising them, and processes for their preparation; also disclosed is a method of treating depression, attention deficit hyperactivity disorder (ADHD), obesity, migraine, sexual dysfunction, Parkinson's disease, Alzheimer's disease, or addiction to cocaine or nicotine-containing (especially tobacco) products using such compound, salts, solvates or compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.